Table 3.
Regional differences for genetic testing in DCM
| All (N = 1260) | FDCM (N = 238) | SDCM (N = 707) | P‐value a | |
|---|---|---|---|---|
| North Europe (n = 179) | 37 (21%) | 19 (56%) | 11 (16%) | <0.001 |
| South Europe (n = 425) | 116 (27%) | 74 (59%) | 23 (14%) | <0.001 |
| West Europe (n = 206) | 48 (23%) | 15 (56%) | 24 (16%) | <0.001 |
| East Europe (n = 302) | 13 (4%) | 6 (18%) | 0 (0%) | <0.001 |
| North Africa (n = 38) | 0 (0%) | 0 (0%) | 0 (0%) | NC |
| Total (1150) | 214 (17%) | 114 (48%) | 58 (8%) | <0.001 |
NC, not calculable.
In 110 cases, genetic testing was unknown.
a
FDCM versus SDCM.